Florida's 2025 childhood-health laws are a meaningful start—but newborns and student athletes aren't the only kids who benefit from genetic insight. The case for making pediatric genetic screening available to every child as preventive medicine.
Our new white paper, now available in AHIP's resource library, lays out the case that identifying genetic risk early—well before age 5—can improve children's health outcomes while lowering long-term costs for health plans.
Read on ahip.org ↗
GeneSprout has joined AHIP, the national trade association representing the health insurance industry, as an Associate Affiliate Organization — strengthening its commitment to advancing pediatric genetic screening in collaboration with leading health plans.
A new JAMA viewpoint argues that rare genetic diseases are a core health system problem, not a niche concern. Here's what the research says — and how GeneSprout is helping families, providers, and health plans act on it.
From GINA to HIPAA to state-level protections, here's how your child's genetic information is legally protected and how GeneSprout safeguards your data.
Two forces have converged to make this the moment for genomics in everyday medicine—dramatically lower costs and an unprecedented expansion of scientific knowledge.
